Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations

Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations

Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations

Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations - Business News Week

Lowest-ever Scope 1 and Scope 2 emissions mark a milestone year in the Company’s SBTi-approved decarbonisation journey MUMBAI, India, Aug. 26, 2026 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today released its Sustainability Report 2025–26, showcasing significant progress across its environmental, social and governance (ESG) priorities. Anchored […] The post Piramal Pharma Stre…

Piramal Pharma strengthens future ready operations with 22.6% emissions reduction

Piramal Pharma, a leading global pharmaceuticals company, released its Sustainability Report 2025–26, showcasing significant progress across its environmental, social and governance (ESG) priorities. Anchored by the theme “Advancing Innovation, Leveraging Sustainability,” the report highlights how sustainability continues to be integrated into the Company’s strategy, operations and innovation agenda while creating long-term value for patients, c…